FibroGen Inc (FGEN)
1.165
-0.04
(-3.72%)
USD |
NASDAQ |
May 10, 16:00
1.165
0.00 (0.00%)
After-Hours: 19:39
FibroGen 1 Year Total Returns (Daily): -93.05% for May 9, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 09, 2024 | -93.05% |
May 08, 2024 | -93.64% |
May 07, 2024 | -92.13% |
May 06, 2024 | -93.34% |
May 03, 2024 | -93.15% |
May 02, 2024 | -92.99% |
May 01, 2024 | -92.91% |
April 30, 2024 | -93.46% |
April 29, 2024 | -93.63% |
April 26, 2024 | -93.62% |
April 25, 2024 | -93.78% |
April 24, 2024 | -94.17% |
April 23, 2024 | -94.75% |
April 22, 2024 | -94.41% |
April 19, 2024 | -94.36% |
April 18, 2024 | -94.29% |
April 17, 2024 | -93.83% |
April 16, 2024 | -93.38% |
April 15, 2024 | -93.33% |
April 12, 2024 | -93.06% |
April 11, 2024 | -92.65% |
April 10, 2024 | -92.55% |
April 09, 2024 | -92.29% |
April 08, 2024 | -91.68% |
April 05, 2024 | -91.41% |
Date | Value |
---|---|
April 04, 2024 | -91.59% |
April 03, 2024 | -92.27% |
April 02, 2024 | -88.42% |
April 01, 2024 | -87.35% |
March 28, 2024 | -87.51% |
March 27, 2024 | -86.21% |
March 26, 2024 | -86.56% |
March 25, 2024 | -85.45% |
March 22, 2024 | -86.13% |
March 21, 2024 | -87.48% |
March 20, 2024 | -88.20% |
March 19, 2024 | -88.25% |
March 18, 2024 | -89.15% |
March 15, 2024 | -89.55% |
March 14, 2024 | -89.58% |
March 13, 2024 | -90.00% |
March 12, 2024 | -90.61% |
March 11, 2024 | -91.50% |
March 08, 2024 | -91.44% |
March 07, 2024 | -91.61% |
March 06, 2024 | -91.39% |
March 05, 2024 | -91.24% |
March 04, 2024 | -91.01% |
March 01, 2024 | -91.70% |
February 29, 2024 | -92.30% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-97.65%
Minimum
Nov 10 2023
119.4%
Maximum
May 09 2023
-27.80%
Average
-28.82%
Median
Aug 27 2019
1 Year Total Returns (Daily) Benchmarks
Annovis Bio Inc | -59.26% |
Emergent BioSolutions Inc | -54.95% |
Vertex Pharmaceuticals Inc | 21.51% |
Geron Corp | 38.43% |
Regeneron Pharmaceuticals Inc | 28.23% |